Skip to content
Know Cancer

Prostate Cancer Screening: What to Know About the PSA Test

November 21, 2026 · Prostate Cancer, Cancer Screening

A man talks with his doctor at her desk.
Photo: Vitaly Gariev on Unsplash

November is a month for men's health, thanks in part to the "Movember" campaign, and prostate cancer is a big part of that conversation. It's one of the most common cancers in American men. The PSA blood test can help find it early, but whether to get tested is a personal decision. Here's what you need to know to make it.

Prostate cancer by the numbers

The American Cancer Society estimates about 333,830 new cases of prostate cancer and about 36,320 deaths in the U.S. in 2026. About 1 in 8 men will be diagnosed during their lifetime. It's the second leading cause of cancer death in American men, after lung cancer, and about 1 in 49 men will die of it. About 6 in 10 cases are found in men 65 or older, and the average age at diagnosis is about 68. Black men are at higher risk of getting prostate cancer and of dying from it.

What the PSA test measures

PSA, or prostate-specific antigen, is a protein made by both normal and cancerous cells in the prostate. The test measures how much is in your blood. A higher level can be a sign of prostate cancer, but there's no single PSA level that proves or rules out cancer, and PSA can rise for other reasons, including:

  • an enlarged prostate (benign prostatic hyperplasia, or BPH)
  • inflammation or infection of the prostate (prostatitis)
  • a recent prostate biopsy
  • ejaculation or vigorous exercise such as cycling, which can cause a short-term rise

Some medicines for an enlarged prostate, such as finasteride and dutasteride, lower PSA, so tell your doctor if you take them.

When to talk to your doctor about screening

Medical groups agree that screening should be a shared decision between you and your doctor, made after you understand the pros and cons.

  • The U.S. Preventive Services Task Force (USPSTF) recommends that men ages 55 to 69 make an individual decision about PSA screening with their clinician. It recommends against routine PSA screening for men 70 and older. The task force is currently working on an update to this recommendation.
  • The American Cancer Society recommends starting the conversation:
    • at 50 for men at average risk who are expected to live at least 10 more years;
    • at 45 for men at high risk, including Black men and men whose father or brother was diagnosed before age 65;
    • at 40 for men at even higher risk, such as those with more than one close relative diagnosed at an early age.

If you choose to be screened and your PSA is below 2.5 ng/mL, the American Cancer Society says retesting every 2 years may be enough. If it's 2.5 or higher, yearly testing is recommended. A digital rectal exam may also be part of screening.

The possible benefits

Screening can find prostate cancer before it spreads. According to the USPSTF's review of the evidence, screening men 55 to 69 may prevent about 1.3 deaths from prostate cancer and about 3 cases of cancer that has spread, for every 1,000 men screened over about 13 years. That's a real but modest benefit, and it may take years to show.

The possible downsides

  • False alarms. In one large trial, more than 15% of men had at least one false-positive result over 10 years. Only about 1 in 4 men who have a biopsy because of a high PSA turn out to have cancer.
  • Biopsy problems. About 1% of men need to be hospitalized for complications such as infection after a biopsy.
  • Overdiagnosis. The USPSTF estimates that 20% to 50% of cancers found by screening would never have caused symptoms or harm in a man's lifetime.
  • Treatment side effects. After surgery to remove the prostate, about 1 in 5 men have long-term urine leakage and about 2 in 3 have long-term erection problems.

One important change has reduced some of these harms: many men with low-risk prostate cancer are now watched closely with active surveillance, with regular tests, instead of being treated right away. Treatment starts only if the cancer shows signs of growing.

What happens after a high PSA

A single high result doesn't mean you have cancer. According to the National Cancer Institute, the usual next step is to repeat the test in 6 to 8 weeks. If it stays high or keeps rising, your doctor may suggest other blood or urine tests or an MRI of the prostate, and possibly a biopsy, in which small samples of tissue are taken with a needle and checked for cancer. MRI can help target the biopsy to suspicious areas. Learn more about the PSA test.

Questions to ask your doctor

  • Based on my age, health and family history, what's my risk of prostate cancer?
  • What are the chances screening would help me, and what are the chances of a false alarm?
  • If my PSA is high, what would the next steps be?
  • If cancer is found, would active surveillance be an option?

Know the symptoms

Early prostate cancer usually causes no symptoms. Problems such as a weak or slow urine stream, needing to urinate more often at night, blood in the urine or semen, or bone pain in the hips or back are more often caused by something else, such as an enlarged prostate, but tell your doctor about them so the cause can be found. See our guide to prostate cancer symptoms. If you've been diagnosed, our prostate cancer treatment guide, our directory of oncologists and our list of prostate cancer clinical trials can help.

The bottom line

The PSA test can find prostate cancer early, but it also leads to false alarms and to finding some cancers that would never cause harm. If you're 50 or older, or 40 to 45 with higher risk, have a conversation with your doctor and decide together whether screening is right for you.

This article is for general information and is not medical advice. Talk with your doctor about your own situation.

Sources